Table 2 Correlation between TRPS1 expression and clinicopathologic features of patients with ovarian clear cell carcinoma
Characteristics | TRPS1-low | TRPS1-high | P value |
|---|---|---|---|
n | 27 | 23 | Â |
Age, mean ± sd | 51.852 ± 10.365 | 51.043 ± 9.4363 | 0.776 |
BMI, median (IQR) | 23.634 (22.049, 25.304) | 21.514 (19.9, 25.381) | 0.119 |
Pathologic.stage, n (%) | Â | Â | 0.143 |
IV | 2 (4%) | 4 (8%) | Â |
III | 7 (14%) | 7 (14%) | Â |
II | 1 (2%) | 4 (8%) | Â |
I | 17 (34%) | 8 (16%) | Â |
Clinical stage, n (%) | Â | Â | 0.047 |
I | 17 (34%) | 8 (16%) | Â |
II-IV | 10 (20%) | 15 (30%) | Â |
Residual tumor, n (%) | Â | Â | 0.518 |
0 | 25 (50%) | 19 (38%) | Â |
1 | 2 (4%) | 4 (8%) | Â |
Lymph node metastasis, n (%) | Â | Â | 0.027 |
0 | 22 (44%) | 12 (24%) | Â |
1 | 5 (10%) | 11 (22%) | Â |
GP, n (%) | Â | Â | 1.000 |
0 | 3 (6%) | 2 (4%) | Â |
1 | 24 (48%) | 21 (42%) | Â |
Endometriosis, n (%) | Â | Â | 1.000 |
0 | 23 (46%) | 20 (40%) | Â |
1 | 4 (8%) | 3 (6%) | Â |
Family history, n (%) | Â | Â | 0.460 |
0 | 27 (54%) | 22 (44%) | Â |
1 | 0 (0%) | 1 (2%) | Â |